Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
BAM Radiation Oncology from Liège, company number BE0789554066, closed financial year 2025 with a result of € 131,176 after tax. For that financial year BAM Radiation Oncology recorded a gross margin of € 169,704 and equity of € 2,000. Compared with financial year 2024, the result moved from € 153,136 to € 131,176. The company is profitable. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2026.
€ 2,000
▼ 99% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 131,176
▼ 14% vs 2024
Profit after tax over the fiscal year.
€ 312,305
▲ 25% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 390,399 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
€ 13,278
▲ € 11,072 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 723
▼ 63% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 86,811
▲ 54% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 38,833 | € 144,355 | € 198,689 | € 169,704 | ▼ 15% |
| Profit after taxes | € 30,505 | € 110,382 | € 153,136 | € 131,176 | ▼ 14% |
| Equity | € 31,705 | € 133,086 | € 261,222 | € 2,000 | ▼ 99% |
| Total debts | € 30,832 | € 63,180 | € 79,223 | € 419,373 | ▲ € 340,151 |
| Cash | € 10,212 | € 125,055 | € 250,701 | € 312,305 | ▲ 25% |
| Retained profit | € 29,705 | € 131,086 | € 259,222 | € 0 | ▼ 100% |
| Dividend | € 800 | € 9,000 | € 25,000 | € 390,399 | ▲ € 365,399 |
| Balance sheet total | € 62,537 | € 196,267 | € 340,445 | € 421,373 | ▲ 24% |
Key figures of BAM Radiation Oncology, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BAM Radiation Oncology?
What happened at BAM Radiation Oncology in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 131,176 (▼ 14% vs 2024). filed late Source: NBB ↗
- New establishment in Brussel. KBO
- Start of the company according to the CBE. KBO
In short
From € 30,505 profit in 2022 to € 131,176 profit in 2025.
Paid € 123,260 in corporate taxes since 2022.
Best year ever: 2024, with € 153,136 profit.
Paid out € 425,199 in dividends to the owners in total.
A new publication or filing at BAM Radiation Oncology? We notify you, reason included.
Follow BAM Radiation OncologyDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind BAM Radiation Oncology is Mathilde Baré.
Directors
According to the 2025 annual accounts
Mathilde Baré
Director
Establishments
Establishment units
Physical locations of this company
Quai de Rome 17 box 91
4000 Liège
Frans Vekemansstraat 91
1120 Brussel
Active since 10 August 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0789.554.066
- VAT number
- BE 0789.554.066
- Registered office
- Quai de Rome 17 bus 91, 4000 Liège
- Names & denominations
- BAM Radiation Oncology · BAM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 August 2022
- Peppol
- Not registered
- Activities · NACE
Activiteiten van medisch specialisten
Activiteiten van medische beeldvorming en medische laboratoria
Activiteiten van medische laboratoria